Food and Drug Administration Commissioner Robert Califf is disputing a federal payment database that shows he received a financial benefit from a major drugmaker while on a trip last year.

According to agency records, Califf received $363 last year from pharma giant GlaxoSmithKline for lodging and food expenses, a benefit that could be a violation of agency policy. Those records show the benefit was received before Califf became the commissioner, but while he was an employee of the FDA.

Recommended Stories

FDA looks at two painkillers that hinder abuse

FDA leaves millions in user fees on the table

Alzheimer’s and diabetes research way behind